We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

96 hedge funds and large institutions have $168M invested in Surface Oncology, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 16

27% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 26

19% more call options, than puts

Call options by funds: $3.45M | Put options by funds: $2.9M

14% more capital invested

Capital invested by funds: $147M → $168M (+$20.2M)

7% more funds holding

Funds holding: 90 → 96 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
29
Reduced
16
Closed
26
Calls
$3.45M
Puts
$2.9M
Net Calls
+$551K
Net Calls Change
+$191K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$6.59M
3
Morgan Stanley
Morgan Stanley
New York
+$4.05M
4
State Street
State Street
Massachusetts
+$3.22M
5
AIM
ARK Investment Management
Florida
+$3.15M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.52M
2
Verition Fund Management
Verition Fund Management
Connecticut
-$2.85M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.31M
4
DLPIC
Davide Leone & Partners Investment Company
United Kingdom
-$2.1M
5
HF
HRT Financial
New York
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$33.4M +$3.15M +409,291 +10%
AVAI
2
Atlas Venture Associates IX
Massachusetts
$22M – – –
BlackRock
3
BlackRock
New York
$19M +$12.2M +1,580,573 +164%
Citadel Advisors
4
Citadel Advisors
Florida
$13.4M +$6.59M +855,239 +90%
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.92M +$871K +113,010 +10%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$7.63M – – –
FCM
7
Farallon Capital Management
California
$7.46M – – –
Goldman Sachs
8
Goldman Sachs
New York
$5.72M +$1.95M +253,159 +49%
Morgan Stanley
9
Morgan Stanley
New York
$5.47M +$4.05M +525,356 +253%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$4.67M +$963K +125,002 +25%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$3.68M +$2.45M +318,084 +182%
State Street
12
State Street
Massachusetts
$3.25M +$3.22M +418,328 +2,324%
Macquarie Group
13
Macquarie Group
Australia
$2.61M – – –
Victory Capital Management
14
Victory Capital Management
Texas
$2.58M -$168K -21,810 -6%
Northern Trust
15
Northern Trust
Illinois
$2.14M +$1.91M +247,492 +631%
Deutsche Bank
16
Deutsche Bank
Germany
$1.75M +$152K +19,753 +9%
PHP
17
Parkman Healthcare Partners
Connecticut
$1.7M -$185K -23,977 -10%
WP
18
Woodline Partners
California
$1.47M +$1.52M +196,629 New
ACM
19
ACT Capital Management
Pennsylvania
$1.27M +$1.31M +170,500 New
Principal Financial Group
20
Principal Financial Group
Iowa
$1.21M +$1.24M +161,481 New
Stifel Financial
21
Stifel Financial
Missouri
$1.19M +$447K +57,974 +57%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.19M +$634K +82,268 +107%
GCP
23
GSA Capital Partners
United Kingdom
$859K +$887K +115,147 New
KOCAA
24
Knights of Columbus Asset Advisors
Connecticut
$847K +$3.11K +403 +0.4%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$831K +$295K +38,284 +52%
1
2 3 4 5

SURF Hedge Fund Activity: Q2 2021 in Review

96 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q2 2021, worth a combined $168M — up 14% from $147M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SURF positions and 26 closed out — a net gain of 7 holders — while 29 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $4.52M sold.

  • 96 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q2 2021, up from 90 in Q1 2021.
  • Funds reported $168M of Surface Oncology, Inc. Common Stock stock for Q2 2021, up 14% quarter-over-quarter.
  • 33 funds opened new Surface Oncology, Inc. Common Stock positions in Q2 2021 and 26 closed out, a net change of +7 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $12.2M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q2 2021 was Acadian Asset Management, an estimated $4.52M sold.

Based on aggregated 13F filings for Q2 2021.